N6-Methyladenosine RNA Modification in Inflammation: Roles, Mechanisms, and Applications

被引：84
作者：
Luo, Jiahui [1 ]
Xu, Tao [2 ]
Sun, Kai [3 ]
机构：
[1] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Ctr Biomed Res, Wuhan, Peoples R China
[2] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Rehabil, Wuhan, Peoples R China
[3] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Orthoped, Wuhan, Peoples R China
来源：
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY | 2021年 / 9卷
基金：
中国国家自然科学基金;
关键词：
N6-methyladenosine; RNA modification; epigenetics; inflammation; inflammatory disease; C-REACTIVE PROTEIN; BODY-MASS INDEX; MESSENGER-RNA; M(6)A METHYLTRANSFERASE; COMPREHENSIVE ANALYSIS; EPITHELIAL-CELLS; GUT MICROBIOTA; NUCLEAR-RNA; METHYLATION; N-6-METHYLADENOSINE;
D O I：
10.3389/fcell.2021.670711
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
N6-methyladenosine (m6A) is the most prevalent internal mRNA modification. m6A can be installed by the methyltransferase complex and removed by demethylases, which are involved in regulating post-transcriptional expression of target genes. RNA methylation is linked to various inflammatory states, including autoimmunity, infection, metabolic disease, cancer, neurodegenerative diseases, heart diseases, and bone diseases. However, systematic knowledge of the relationship between m6A modification and inflammation in human diseases remains unclear. In this review, we will discuss the association between m6A modification and inflammatory response in diseases, especially the role, mechanisms, and potential clinical application of m6A as a biomarker and therapeutic target for inflammatory diseases.
引用
收藏
页数：13
相关论文
共 50 条
[41]   Emerging Roles of N6-Methyladenosine on HIV-1 RNA Metabolism and Viral Replication [J].
Riquelme-Barrios, Sebastian ;
Pereira-Montecinos, Camila ;
Valiente-Echeverria, Fernando ;
Soto-Rifo, Ricardo .
FRONTIERS IN MICROBIOLOGY, 2018, 8
[42]   N6-methyladenosine RNA methylation: From regulatory mechanisms to potential clinical applications [J].
Li, Peipei ;
Wang, Yuntao ;
Sun, Yiwen ;
Jiang, Sanjie ;
Li, Jingjing .
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2022, 10
[43]   RNA N6-methyladenosine modification in solid tumors: new therapeutic frontiers [J].
Melstrom, Laleh ;
Chen, Jianjun .
CANCER GENE THERAPY, 2020, 27 (09) :625-633
[44]   New horizons for the role of RNA N6-methyladenosine modification in hepatocellular carcinoma [J].
Li, Yu-jia ;
Qiu, Yang-ling ;
Li, Meng-ran ;
Shen, Min ;
Zhang, Feng ;
Shao, Jiang-juan ;
Xu, Xue-fen ;
Zhang, Zi-li ;
Zheng, Shi-zhong .
ACTA PHARMACOLOGICA SINICA, 2024, 45 (06) :1130-1141
[45]   N6-methyladenosine modification underlies messenger RNA metabolism and plant development [J].
Shao, Yanlin ;
Wong, Chui Eng ;
Shen, Lisha ;
Yu, Hao .
CURRENT OPINION IN PLANT BIOLOGY, 2021, 63
[46]   Novel Insights Into the Multifaceted Functions of RNA n6-Methyladenosine Modification in Degenerative Musculoskeletal Diseases [J].
Li, Hengzhen ;
Xiao, WenFeng ;
He, Yuqiong ;
Wen, Zeqin ;
Cheng, Siyuan ;
Zhang, Yi ;
Li, Yusheng .
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 9
[47]   Role of N6-methyladenosine RNA modification in cancer [J].
Qu, Yi ;
Gao, Nannan ;
Zhang, Shengwei ;
Gao, Limin ;
He, Bing ;
Wang, Chao ;
Gong, Chunli ;
Shi, Qiuyue ;
Li, Zhibin ;
Yang, Shiming ;
Xiao, Yufeng .
MEDCOMM, 2024, 5 (09)
[48]   Role of identified RNA N6-methyladenosine methylation in liver [J].
Xu, Kechen ;
Sun, Yuchao ;
Sheng, Baixiang ;
Zheng, Yiwen ;
Wu, Xiaoli ;
Xu, Keyang .
ANALYTICAL BIOCHEMISTRY, 2019, 578 :45-50
[49]   N6-Methyladenosine: A Novel RNA Imprint in Human Cancer [J].
Yu, Sihui ;
Li, Xi ;
Liu, Shiyun ;
Yang, Rui ;
Liu, Xiangnan ;
Wu, Sufang .
FRONTIERS IN ONCOLOGY, 2019, 9
[50]   The emerging roles of N6-methyladenosine RNA methylation in human cancers [J].
Huafei Shen ;
Yifen Lan ;
Yanchun Zhao ;
Yuanfei Shi ;
Jie Jin ;
Wanzhuo Xie .
Biomarker Research, 8
12345